Friedman Bart
SEC insider (Form 3/4/5 filer). CIK 0001368324. Director at Ovid Therapeutics Inc. (OVID). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in NEW YORK, NY.
Companies Friedman Bart has filed insider reports for
- Ovid Therapeutics Inc. (OVID): Director
Friedman Bart
CIK: 0001368324
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Ovid Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 7, 2026OVID
Ovid Therapeutics Inc.
AwardDirect8.8K shares at avg. $2.56$22K - Feb 26, 2026OVID
Ovid Therapeutics Inc.
AwardDirectEmployee Stock Option (Right to Buy)
65K shares- - Feb 20, 2025OVID
Ovid Therapeutics Inc.
AwardDirectStock Option (right to buy)
45K shares- - Dec 12, 2024OVID
Ovid Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
90K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 7, 2026 | OVID Ovid Therapeutics Inc. | Award | 8,789 | $2.56 | $22,500 | Direct |
| Feb 26, 2026 | OVID Ovid Therapeutics Inc. | Award Employee Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Feb 20, 2025 | OVID Ovid Therapeutics Inc. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
| Dec 12, 2024 | OVID Ovid Therapeutics Inc. | Award Stock Option (Right to Buy) | 90,000 | - | - | Direct |
1-4 of 4 transactions